The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

Patients taking compounded weight loss drugs from online pharmacies share what it's like — and they couldn't go the ...

Explore what to expect now that the Hims & Hers stock price now that it has crashed hard in the past few weeks.

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

In a tell-all interview with SELF magazine, Remi Bader opened up about her weight loss for the first time, revealing that she ...

Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...

A Fremont business owner was arrested on March 12 and charged with prescribing prescription drugs without a license and ...

Novo Nordisk will pay $200 million up front, with up to $1.8 billion in additional payments down the line, The Wall Street ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

Last week marked the FDA's deadline for compounders to stop making the obesity drug tirzepatide (Zepbound), leaving some ...

The newest generation of GLP-1 drugs has delivered life-changing benefits to patients managing diabetes, obesity, heart ...